Clinical Trial Update: Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer [Phase 2]

View source ↗

Summary

This entry reports a Phase II trial evaluating maintenance capecitabine for resectable colorectal cancer. The status of the trial is listed as UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Colorectal Neoplasms | Phase 2 | Status: UNKNOWN